Cibc World Market Inc. boosted its position in Centene Corporation (NYSE:CNC – Free Report) by 410.7% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 395,879 shares of the company’s stock after buying an additional 318,360 shares during the period. Cibc World Market Inc.’s holdings in Centene were worth $24,592,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors also recently bought and sold shares of CNC. BlackRock Inc. acquired a new position in shares of Centene during the second quarter worth about $2,660,422,000. Wellington Management Group LLP lifted its position in Centene by 423.0% in the second quarter. Wellington Management Group LLP now owns 13,301,215 shares of the company’s stock valued at $853,805,000 after purchasing an additional 10,757,914 shares during the period. Bank of America Corp DE acquired a new stake in Centene in the second quarter valued at about $285,713,000. Deutsche Bank AG purchased a new stake in Centene in the 2nd quarter valued at approximately $257,279,000. Finally, Legal & General Group Plc purchased a new stake in Centene in the 2nd quarter valued at approximately $244,463,000. 93.63% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Centene news, General Counsel Christopher Koster sold 56,500 shares of the firm’s stock in a transaction dated Wednesday, August 26th. The shares were sold at an average price of $66.90, for a total transaction of $3,779,850.00. Following the completion of the transaction, the general counsel directly owned 248,854 shares in the company, valued at approximately $16,648,332.60. This trade represents a 18.50% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.37% of the company’s stock.
Wall Street Analyst Weigh In
CNC has been the topic of a number of analyst reports. Stifel Nicolaus set a $79.00 price target on Centene in a research note on Monday, August 3rd. JPMorgan Chase & Co. set a $90.00 price objective on Centene in a research report on Tuesday. Morgan Stanley set a $71.00 target price on Centene and gave the company an “equal weight” rating in a report on Wednesday, October 28th. Bank of America restated a “buy” rating and set a $82.00 target price (up from $80.00) on shares of Centene in a research report on Wednesday, October 28th. Finally, Robert W. Baird boosted their target price on shares of Centene from $66.00 to $71.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 28th. Nine analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $75.10.
Read Our Latest Analysis on Centene
Centene Stock Down 6.8%
Centene stock opened at $67.64 on Thursday. Centene Corporation has a fifty-two week low of $31.63 and a fifty-two week high of $78.08. The firm has a market capitalization of $33.49 billion, a price-to-earnings ratio of 23.17, a price-to-earnings-growth ratio of 0.42 and a beta of 1.07. The stock’s fifty day moving average is $67.45 and its two-hundred day moving average is $56.94. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.16 and a current ratio of 1.16.
Centene (NYSE:CNC – Get Free Report) last released its quarterly earnings results on Tuesday, October 27th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.48. Centene had a return on equity of 12.15% and a net margin of 0.72%. The business had revenue of $50.65 billion during the quarter, compared to the consensus estimate of $47.12 billion. During the same quarter in the previous year, the company posted $0.50 EPS. The business’s revenue was up 1.9% on a year-over-year basis. Analysts predict that Centene Corporation will post 5.27 EPS for the current fiscal year.
Centene Profile
Centene Corporation is a U.S. health care company that provides managed care and related services, primarily for people enrolled in government-sponsored health programs. Its offerings include Medicaid and Medicare plans, as well as health insurance sold through the Affordable Care Act marketplace. Centene serves members through health plans and a network of health care providers. Its businesses include Ambetter, which offers marketplace health plans, and Wellcare, which provides Medicare-related coverage.
Recommended Stories
- Five stocks we like better than Centene
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
